重度哮喘的管理：欧洲呼吸学会/美国胸科学会特别工作组报告摘要
Management of severe asthma: summary of the European Respiratory Society/American Thoracic Society task force report.
作者信息
Khurana Sandhya, Bush Andrew, Holguin Fernando
机构信息
University of Rochester School of Medicine and Dentistry, Pulmonary and Critical Care Medicine, Rochester, NY, USA.
Dept of Paediatrics, National Heart & Lung Institute, Imperial College London, London, UK.
出版信息
Breathe (Sheff). 2020 Jun;16(2):200058. doi: 10.1183/20734735.0058-2020.
This article is mainly intended for trainees and specialists who are interested in the management of severe asthma. It aims to inform readers about the updated ERS/ATS recommendations for management of severe asthma, specifically on the topics of biologics, macrolides and long-acting muscarinic antagonists.It also provides guidance on utilisation of available biomarkers in selecting advanced therapies in severe asthma.
本文主要面向对重度哮喘管理感兴趣的学员和专家。其目的是让读者了解欧洲呼吸学会（ERS）/美国胸科学会（ATS）关于重度哮喘管理的最新建议，特别是关于生物制剂、大环内酯类药物和长效毒蕈碱拮抗剂的主题。它还为在重度哮喘中选择先进疗法时利用可用生物标志物提供指导。
Zotero 插件